96 related articles for article (PubMed ID: 18156608)
1. Minor emtricitabine intolerance in treatment-stable patients switched from tenofovir/lamivudine to a fixed-dose combination of tenofovir/emtricitabine (Truvada).
Palacios R; Terrón A; Hidalgo A; Rivero A; Santos J;
J Antimicrob Chemother; 2008 Feb; 61(2):462-3. PubMed ID: 18156608
[No Abstract] [Full Text] [Related]
2. Meeting notes from ICAAC. Tenofovir + emtricitabine vs. AZT + 3TC.
Feinberg J
AIDS Clin Care; 2005 Jan; 17(1):7. PubMed ID: 15717373
[No Abstract] [Full Text] [Related]
3. Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study.
Stellbrink HJ; Orkin C; Arribas JR; Compston J; Gerstoft J; Van Wijngaerden E; Lazzarin A; Rizzardini G; Sprenger HG; Lambert J; Sture G; Leather D; Hughes S; Zucchi P; Pearce H;
Clin Infect Dis; 2010 Oct; 51(8):963-72. PubMed ID: 20828304
[TBL] [Abstract][Full Text] [Related]
4. Anti-HIV agents. Dueling nukes: AZT + 3TC vs. tenofovir + FTC.
TreatmentUpdate; 2005; 17(5):5-7. PubMed ID: 17225279
[No Abstract] [Full Text] [Related]
5. Combination antiretroviral therapy with tenofovir, emtricitabine or lamivudine, and nevirapine.
Redfield RR; Morrow JS
Clin Infect Dis; 2008 Oct; 47(7):984-5. PubMed ID: 18778234
[No Abstract] [Full Text] [Related]
6. [First line therapy. Tenofovir DF/emtricitabine--the potent backbone].
MMW Fortschr Med; 2008 Apr; 150 Spec No 1():12-4. PubMed ID: 19024908
[No Abstract] [Full Text] [Related]
7. Steady-state pharmacokinetics of emtricitabine and tenofovir disoproxil fumarate administered alone and in combination in healthy volunteers.
Blum MR; Chittick GE; Begley JA; Zong J
J Clin Pharmacol; 2007 Jun; 47(6):751-9. PubMed ID: 17519400
[TBL] [Abstract][Full Text] [Related]
8. The art of managing human immunodeficiency virus infection: a balancing act.
Reiss P
Clin Infect Dis; 2009 Nov; 49(10):1602-4. PubMed ID: 19842978
[No Abstract] [Full Text] [Related]
9. [Two novel fixed formulations of nucleoside analogues (tenofovir-emtricitabine, and abacavir-lamivudine). Prospective, open study on clinical practice and therapeutic perspectives, in patients naïve and in subjects pre-treated with antiretrovirals].
Manfredi R; Calza L
Recenti Prog Med; 2008 Oct; 99(10):492-501. PubMed ID: 19040127
[TBL] [Abstract][Full Text] [Related]
10. Tenofovir disoproxil fumarate-emtricitabine coformulation for once-daily dual NRTI backbone.
Muñoz de Benito RM; Arribas López JR
Expert Rev Anti Infect Ther; 2006 Aug; 4(4):523-35. PubMed ID: 17009933
[TBL] [Abstract][Full Text] [Related]
11. Tenofovir regimen compared with Combivir.
AIDS Patient Care STDS; 2005 Jan; 19(1):59-60. PubMed ID: 15700398
[No Abstract] [Full Text] [Related]
12. Tenofovir/emtricitabine combination results in lower bone-mineral density.
AIDS Patient Care STDS; 2010 Apr; 24(4):265-6. PubMed ID: 20405529
[No Abstract] [Full Text] [Related]
13. Two-once-daily fixed-dose NRTI combinations for HIV.
Med Lett Drugs Ther; 2005 Feb; 47(1203):19-20. PubMed ID: 15767973
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of tenofovir-emtricitabine versus abacavir-lamivudine.
Landman GW; Soonawala D
Clin Infect Dis; 2010 Apr; 50(8):1200; author reply 1200. PubMed ID: 20233045
[No Abstract] [Full Text] [Related]
15. Risk of early virological failure of once-daily tenofovir-emtricitabine plus twice-daily nevirapine in antiretroviral therapy-naive HIV-infected patients.
Lapadula G; Costarelli S; Quiros-Roldan E; Calabresi A; Izzo I; Carosi G; Torti C
Clin Infect Dis; 2008 Apr; 46(7):1127-9. PubMed ID: 18444839
[No Abstract] [Full Text] [Related]
16. Rapid improvement in fasting lipids and hepatic toxicity after switching from didanosine/lamivudine to tenofovir/emtricitabine in patients with toxicity attributable to didanosine.
Palacios R; Rivero A; Santos I; Ríos MJ; Castaño M; del Arco A; Santos González J;
HIV Clin Trials; 2010; 11(2):118-20. PubMed ID: 20542848
[No Abstract] [Full Text] [Related]
17. Tapping into combination pills for HIV.
Hughes B
Nat Rev Drug Discov; 2009 Jun; 8(6):439-40. PubMed ID: 19483700
[No Abstract] [Full Text] [Related]
18. Tenofovir-based rescue therapy for advanced liver disease in 6 patients coinfected with HIV and hepatitis B virus and receiving lamivudine.
Gutiérrez S; Guillemi S; Jahnke N; Montessori V; Harrigan PR; Montaner JS
Clin Infect Dis; 2008 Feb; 46(3):e28-30. PubMed ID: 18181733
[TBL] [Abstract][Full Text] [Related]
19. The CASTLE study: atazanavir/r versus lopinavir/r in antiretroviral-naive patients.
Chetchotisakd P
Expert Rev Anti Infect Ther; 2009 Sep; 7(7):801-5. PubMed ID: 19735222
[TBL] [Abstract][Full Text] [Related]
20. [Simply convincing. New fixed combination for HIV therapy].
MMW Fortschr Med; 2005 Apr; 147 Spec No 1():20-3. PubMed ID: 16385865
[No Abstract] [Full Text] [Related]
[Next] [New Search]